|
|
(15 intermediate revisions by 3 users not shown) |
Line 1: |
Line 1: |
| {{SMMU-China}} | | {{SMMU-China}} |
| <html> | | <html> |
− | <link rel="stylesheet" href="https://2018.igem.org/Template:SMMU-China/CSS_main?action=raw&ctype=text/css" type="text/css"> | + | <link rel="stylesheet" href="https://2018.igem.org/Template:SMMU-China/CSS_main?action=raw&ctype=text/css" type="text/css"> |
− | <link rel="stylesheet" href="https://2018.igem.org/wiki/index.php?title=Template:SMMU-China/CSS_ToTheTop&action=raw&ctype=text/css" /> | + | <link rel="stylesheet" href="https://2018.igem.org/wiki/index.php?title=Template:SMMU-China/CSS_ToTheTop&action=raw&ctype=text/css" /> |
| + | |
| + | <link rel="stylesheet" href="https://2018.igem.org/wiki/index.php?title=Template:SMMU-China/2019_CSS_demo&action=raw&ctype=text/css" /> |
| + | <link rel="stylesheet" href="http://fonts.googleapis.com/icon?family=Material+Icons&action=raw&ctype=text/css" /> |
| + | <link rel="stylesheet" href="https://2018.igem.org/wiki/index.php?title=Template:SMMU-China/2019_CSS_sidenav_min&action=raw&ctype=text/css" /> |
| + | <style type="text/css"> |
| + | .toggle { |
| + | display: block; |
| + | height: 72px; |
| + | line-height: 72px; |
| + | text-align: center; |
| + | width: 72px; |
| + | } |
| + | </style> |
| <div id="page-wrapper"> | | <div id="page-wrapper"> |
| <!-- Header --> | | <!-- Header --> |
| <section id="header"> | | <section id="header"> |
| | | |
− | <table> | + | <div id="needshow" style="display: none;"> |
| + | <h1><a href="https://2018.igem.org/Team:SMMU-China">Ca<sup>2+</sup>RTIN</a></h1> |
| + | <center> |
| + | <a href="javascript:;" class="toggle" id="sidenav-toggle"> |
| + | <i class="material-icons" style="line-height:3;font-size:40px;">menu</i> |
| + | </a> |
| + | <p style="font-size: 20px;margin-top: 2em;font-weight: 700;">Please view this page horizontally!</p> |
| + | </center> |
| + | |
| + | |
| + | </div> |
| + | |
| + | <table id="needhide" style="margin-bottom:0;"> |
| <tr> | | <tr> |
| <th style="float:left;margin-left:40px"> | | <th style="float:left;margin-left:40px"> |
Line 70: |
Line 95: |
| <tr> | | <tr> |
| </table> | | </table> |
| + | |
| + | <nav class="sidenav" data-sidenav data-sidenav-toggle="#sidenav-toggle"> |
| + | <div class="sidenav-brand"> |
| + | MENU |
| + | </div> |
| + | |
| + | <ul class="sidenav-menu"> |
| + | <li> |
| + | <a href="https://2018.igem.org/Team:SMMU-China"> |
| + | <span class="sidenav-link-icon"> |
| + | <i class="material-icons">assignment_ind</i> |
| + | </span> |
| + | <span class="sidenav-link-title">Home</span> |
| + | </a> |
| + | </li> |
| + | <li> |
| + | <a href="https://2018.igem.org/Team:SMMU-China/Description" data-sidenav-dropdown-toggle class="active"> |
| + | <span class="sidenav-link-icon"> |
| + | <i class="material-icons">store</i> |
| + | </span> |
| + | <span class="sidenav-link-title">Project</span> |
| + | <span class="sidenav-dropdown-icon show" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_down</i> |
| + | </span> |
| + | <span class="sidenav-dropdown-icon" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_up</i> |
| + | </span> |
| + | </a> |
| + | |
| + | <ul class="sidenav-dropdown" data-sidenav-dropdown> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Description">Description</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Design">Design</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Experiments">Experiments</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Demonstrate">Demonstrate</a></li> |
| + | </ul> |
| + | </li> |
| + | <li> |
| + | <a href="https://2018.igem.org/Team:SMMU-China/Basic_Part" data-sidenav-dropdown-toggle class="active"> |
| + | <span class="sidenav-link-icon"> |
| + | <i class="material-icons">store</i> |
| + | </span> |
| + | <span class="sidenav-link-title">Parts</span> |
| + | <span class="sidenav-dropdown-icon show" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_down</i> |
| + | </span> |
| + | <span class="sidenav-dropdown-icon" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_up</i> |
| + | </span> |
| + | </a> |
| + | |
| + | <ul class="sidenav-dropdown" data-sidenav-dropdown> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Basic_Part">Basic Part</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Composite_Part">Composite Part</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Part_Collection">Part Collection</a></li> |
| + | </ul> |
| + | </li> |
| + | <li> |
| + | <a data-sidenav-dropdown-toggle class="active"> |
| + | <span class="sidenav-link-icon"> |
| + | <i class="material-icons">store</i> |
| + | </span> |
| + | <span class="sidenav-link-title">Lab</span> |
| + | <span class="sidenav-dropdown-icon show" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_down</i> |
| + | </span> |
| + | <span class="sidenav-dropdown-icon" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_up</i> |
| + | </span> |
| + | </a> |
| + | |
| + | <ul class="sidenav-dropdown" data-sidenav-dropdown> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Safety">Safety</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Notebook">Notebook</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/InterLab">Interlab</a></li> |
| + | </ul> |
| + | </li> |
| + | <li> |
| + | <a href="https://2018.igem.org/Team:SMMU-China/Model" data-sidenav-dropdown-toggle class="active"> |
| + | <span class="sidenav-link-icon"> |
| + | <i class="material-icons">store</i> |
| + | </span> |
| + | <span class="sidenav-link-title">Modeling</span> |
| + | <span class="sidenav-dropdown-icon show" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_down</i> |
| + | </span> |
| + | <span class="sidenav-dropdown-icon" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_up</i> |
| + | </span> |
| + | </a> |
| + | |
| + | <ul class="sidenav-dropdown" data-sidenav-dropdown> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Model">Model</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Software">Software</a></li> |
| + | </ul> |
| + | </li> |
| + | <li> |
| + | <a href="https://2018.igem.org/Team:SMMU-China/Human_Practices" data-sidenav-dropdown-toggle class="active"> |
| + | <span class="sidenav-link-icon"> |
| + | <i class="material-icons">store</i> |
| + | </span> |
| + | <span class="sidenav-link-title">HP</span> |
| + | <span class="sidenav-dropdown-icon show" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_down</i> |
| + | </span> |
| + | <span class="sidenav-dropdown-icon" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_up</i> |
| + | </span> |
| + | </a> |
| + | |
| + | <ul class="sidenav-dropdown" data-sidenav-dropdown> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Human_Practices">Human Practice</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Public_Engagement">Edu&Public Engagement</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Collaborations">Collaboration</a></li> |
| + | </ul> |
| + | </li> |
| + | <li> |
| + | <a href="https://2018.igem.org/Team:SMMU-China/Team" data-sidenav-dropdown-toggle class="active"> |
| + | <span class="sidenav-link-icon"> |
| + | <i class="material-icons">store</i> |
| + | </span> |
| + | <span class="sidenav-link-title">Team</span> |
| + | <span class="sidenav-dropdown-icon show" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_down</i> |
| + | </span> |
| + | <span class="sidenav-dropdown-icon" data-sidenav-dropdown-icon> |
| + | <i class="material-icons">arrow_drop_up</i> |
| + | </span> |
| + | </a> |
| + | |
| + | <ul class="sidenav-dropdown" data-sidenav-dropdown> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Team">Team Members</a></li> |
| + | <li><a href="https://2018.igem.org/Team:SMMU-China/Attributions">Attributions</a></li> |
| + | </ul> |
| + | </li> |
| + | </ul> |
| + | </nav> |
| | | |
| </section> | | </section> |
Line 85: |
Line 246: |
| <section> | | <section> |
| | | |
− | <h3 class="inner-h">Project safety</h3> | + | |
| <p class="inner-text"> | | <p class="inner-text"> |
| Based on the brilliant works of the wet group, as well as for providing a direction for further works, we built two corresponding mathematical models, which could simulate some parts of our experiments in an extent. These two models are respectively counting numbers of calcium sparks and calcium releasing extent affected by phosphorylation of RyR2, and the relationship between phosphorylation level of RyR2 and intrabody AR185. These two models, on the one hand, give us a direction for further works to improve experiment designing and evaluate the therapeutic outcome. On the other hand, the experimental results equally feedback to the models to adjust parameters. | | Based on the brilliant works of the wet group, as well as for providing a direction for further works, we built two corresponding mathematical models, which could simulate some parts of our experiments in an extent. These two models are respectively counting numbers of calcium sparks and calcium releasing extent affected by phosphorylation of RyR2, and the relationship between phosphorylation level of RyR2 and intrabody AR185. These two models, on the one hand, give us a direction for further works to improve experiment designing and evaluate the therapeutic outcome. On the other hand, the experimental results equally feedback to the models to adjust parameters. |
Line 218: |
Line 379: |
| <center><img src="https://static.igem.org/mediawiki/2018/d/db/T--SMMU-China--model9.svg"></center> | | <center><img src="https://static.igem.org/mediawiki/2018/d/db/T--SMMU-China--model9.svg"></center> |
| | | |
| + | <h4 class="inner-h">Application</h4> |
| + | <p class="inner-text"> |
| + | We put all kinds of a constant into the model and calculate in MATLAB to obtain RyR2 opening probability in different local calcium concentration. The result shows RyR2 opening probability increased along with the rise of local calcium concentration. And when calcium concentration reaches a certain extent, RyR2 opening probability approach the maximum we assumed before. |
| + | </p> |
| | | |
| + | |
| + | <center> |
| + | <img src="https://static.igem.org/mediawiki/2018/5/5a/T--SMMU-China--a.jpg" width="400px"> |
| + | </center> |
| + | <br> |
| + | |
| + | <center> |
| + | <img src="https://static.igem.org/mediawiki/2018/f/f8/T--SMMU-China--a1.jpg" width="600px"> |
| + | </center> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/b/bf/T--SMMU-China--a2.jpg" width="600px"></center> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/b/b8/T--SMMU-China--a3.jpg" width="600px"></center> |
| + | |
| + | <p class="inner-text"> |
| + | So, we get a conclusion that in failing cardiac cells hyperphosphorylation of RyR2 and calcium channel instability lead to RyR2 opening probability higher than normal condition, subsequently results in calcium leak, which increases the number of calcium sparks. |
| + | </p> |
| + | |
| + | <br> |
| + | <hr> |
| + | <br> |
| + | <h3 class="inner-h">Intrabody AR185 and phosphorylation of RyR2</h3> |
| + | |
| + | <p class="inner-text"> |
| + | We make this model mainly for stimulating the competition between the protection by intrabody and phosphorylation by protein kinase. A reversible binding holds the protection on RyR2 of our intracellular expressed antibody——AR185. We think it is the same as the classic antibody-antigen binding course, that consists of binding and separation phases. |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/d/d3/T--SMMU-China--model10.svg"></center> |
| + | |
| + | <p class="inner-text"> |
| + | Equally, there is a phosphorylation process happened when a cardiac muscle cell is under attack by heart failure. Because of so many kinds of influence factors when heart failure happened, we chose the targeting point of our intrabody and simplified the influence process into a protein kinase-mediated phosphorylation process of a single point S2808 on RyR2. |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/0/06/T--SMMU-China--model11.svg"></center> |
| | | |
| + | <p class="inner-text"> |
| + | Two processes compete for each other in an influenced cardiac muscle cell. Under the circumstance without the protection of intrabody AR185, most vulnerable sites on the RyR2 will be phosphorylated step by step and affect its channel function. If our intrabody competitively occupies the key site S2808, it will block the phosphorylation so that a part of RyR2 could maintain its regulated calcium releasing function. |
| + | </p> |
| + | |
| + | <p class="inner-text"> |
| + | We made many hypotheses in our model because that heart failure caused by different stimulations have different pathophysiologic environments. In our limited knowledge, we assume that the activity of protein kinase A (PKA) increase along with a timeline of the heart failure progression. And the activity is reflected on the formula by the pattern of the concentration of PKA. Besides, the concentration of ATP is considered as a constant. The total quantity of RyR2 includes the bare RyR2 that without any phosphorylated site and intrabody binding, phosphorylated RyR2 and the RyR2 bound by intrabody AR185. |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/9/98/T--SMMU-China--model12.svg"></center> |
| + | |
| + | <p class="inner-text"> |
| + | According to the law of mass action, we could calculate the reaction rate in different condition: |
| + | </p> |
| + | |
| + | <p class="inner-text"> |
| + | Without intrabody AR185: |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/2/2c/T--SMMU-China--model13.svg"></center> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/c/c9/T--SMMU-China--model14.svg"></center> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/f/f4/T--SMMU-China--model15.svg"></center> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/9/98/T--SMMU-China--model16.svg"></center> |
| + | |
| + | <p class="inner-text"> |
| + | Collectively, we can calculate the phosphorylating rate of RyR2: |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/d/d1/T--SMMU-China--model17.svg"></center> |
| + | |
| + | <p class="inner-text"> |
| + | After integral calculation, the phosphorylated RyR2 become a dependent variable changed with time in failing state. |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/9/98/T--SMMU-China--model18.svg"></center> |
| + | |
| + | <p class="inner-text"> |
| + | With intrabody AR185: |
| + | </p> |
| + | |
| + | <p class="inner-text"> |
| + | When AR185 is expressed in cardiac cell, there would be two reaction compete with each other. |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/4/41/T--SMMU-China--model19.svg"></center> |
| + | |
| + | <p class="inner-text"> |
| + | <small>It is easy to derive the same equations as above.</small> |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/2/2e/T--SMMU-China--model20.svg"></center> |
| + | |
| + | <p class="inner-text"> |
| + | <small>The simultaneous equations could be derived as follow:</small> |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/7/70/T--SMMU-China--model21.svg" style="width: 90%"></center> |
| + | |
| + | <h4 class="inner-h">Application</h4> |
| + | |
| + | <p class="inner-text"> |
| + | We respectively compare two conditions, without and with AR185 competing on RyR2, and calculate the equation set in MATLAB. |
| + | </p> |
| + | |
| + | <p class="inner-text"> |
| + | Without AR185: |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/3/31/T--SMMU-China--without.jpg" width=100%></center> |
| + | |
| + | <p class="inner-text"> |
| + | With AR185: |
| + | </p> |
| + | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/e/e3/T--SMMU-China--with.jpg" width=100%></center> |
| + | |
| + | <p class="inner-text"> |
| + | Consequently, without the intrabody AR185, RyR2 would be catalyzed by PKA and about 50 percent of RyR2 were phosphorylated in our simulation. However, when AR185 expressed in cell plasma, because of the high affinity between AR185 and S2808 site on RyR2, about only 25 percent RyR2 were finally phosphorylated. |
| + | </p> |
| + | |
| </section> | | </section> |
| | | |
Line 322: |
Line 603: |
| }); | | }); |
| </script> | | </script> |
| + | |
| + | <script src="https://2018.igem.org/Template:SMMU-China/2019_JS_jquery_min?action=raw&ctype=text/javascript"></script> |
| + | <script src="https://2018.igem.org/Template:SMMU-China/2019_JS_sidenav_min?action=raw&ctype=text/javascript"></script> |
| + | <script>$('[data-sidenav]').sidenav();</script> |
| | | |
| <p id="last_p_label"> | | <p id="last_p_label"> |
| </html> | | </html> |